Pharmaceutical Good Manufacturing Practice Regulations Article 34

In regard to the quantities of raw materials used by Chinese herbal medicine factories in the manufacture of products, the amounts of active ingredients in each product batch may not fall below the nominal quantity.Weighing, dividing and other procedures carried out on raw materials shall be performed in designated segregation areas, and shall be appropriately supervised and controlled.Documented operational procedures shall include detailed test and control procedures for representative samples from each batch of semi-finished or intermediate products.During the manufacturing and production process, the quality control departments of pharmaceutical factories shall carry out tests on semi-finished or intermediate products in accordance with established test procedures, thereby determining whether to approve aforesaid products for use; semi-finished or intermediate products that are not approved for use shall be labeled to this effect and kept isolated.
中文原文 藥物優良製造準則第34條
中藥廠製造產品之原料使用量,每批產品之有效成分,不得低於其標示量。
原料之秤量、細分或其他作業,應在指定之隔離場所內操作,並予適當監督管制。
書面作業程序,應詳訂每批半製品或中間產品之代表性樣品所應有之檢驗管制程序。
製造生產過程中,藥廠之品質管制部門,應依既定檢驗程序作半製品或中間產品之各項檢驗,並決定准用或拒用;拒用之半製品或中間產品應予標識,並隔離管制。

English translation for reference only; the Chinese text prevails. Not legal advice.